🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
✕
Login
Home
News
Messages
Startup Showcase
Trackers
Premium
Premium Content
Jobs
Notifications
Settings
Try our Valuation Calculator →
Log In
News on Medial
InvAscent looks to log another exit from pharma portfolio
VCCircle
·
3m ago
Medial
InvAscent, a healthcare-focused private equity firm, is planning to exit its over six-year-old investment in an animal pharmaceuticals company, potentially through a secondary transaction. This decision comes as the firm is utilizing its fourth fund and approaching the final closing of the vehicle. The specific details and potential buyers involved in this transaction have not been disclosed, as informed by two people familiar with the situation to VCCircle.
View Source
Related News
InvAscent may get an exit as portfolio firm scouts for new investors
VCCircle
·
1y ago
Medial
A portfolio company of private equity firm InvAscent is in search of new investors, with the possibility of attracting fresh capital and providing an exit strategy for InvAscent. The deal could potentially involve the transfer of a controlling stake in the healthcare-focused portfolio company.
View Source
PE firm InvAscent keen to list five portfolio companies
Livemint
·
1y ago
Medial
Private equity firm InvAscent plans to list five of its portfolio companies in the healthcare and pharmaceutical sectors over the next 24-36 months. The portfolio firms include Symbiotec Pharmalab, Malladi Drugs, Ankura Hospital, Accumax Lab Devices, and MediBuddy. This move will provide exit opportunities for the investor and reflects a strategic shift in their approach. InvAscent has invested in these firms through India Life Sciences Fund III and aims for them to have scaled to ₹150 crore in Ebitda before listing. The firm has previously exited through sales to larger private equity firms or companies.
View Source
InvAscent plots an exit move as healthcare portfolio firm’s IPO plan takes shape
VCCircle
·
4m ago
Medial
InvAscent, a healthcare-focused private equity firm, plans to partially exit its three-year investment in a South India-based bulk drugs manufacturer. The company is preparing for an initial public offering (IPO). This move comes as InvAscent continues to progress with its fourth fund, which reached its halfway mark in June. The anticipated IPO offers an opportunity for InvAscent to reap returns from this strategic investment.
View Source
Affirma Capital moves to score another India exit
VCCircle
·
8m ago
Medial
Emerging markets-focused private equity firm Affirma Capital is aiming to make an exit from another Indian portfolio company while also seeking to raise its first fund dedicated to investing in the South Asian nation. Affirma Capital, which spun out from Standard Chartered Private Equity, is focused on opportunities in the Indian market. The firm's move to exit another portfolio company is part of its strategy to generate returns for its investors.
View Source
BanyanTree sets stage for over 10x exit from legacy PE portfolio
VCCircle
·
1y ago
Medial
Private equity firm BanyanTree Growth Capital is preparing for a lucrative exit by selling its 32.64% stake in GPT Healthcare Ltd. This comes after their recent successful buyback exit from a portfolio company in the education sector. BanyanTree is also aiming for a full exit from another company as they continue to focus on mid-market investments.
View Source
Harsha Raghavan-led PE firm Convergent scores another multi-bagger
VCCircle
·
1y ago
Medial
Convergent Finance, a private equity firm led by Harsha Raghavan, has achieved another successful exit from its portfolio, marking its third such move this year. The firm, which was founded by former Fairfax India executive Harsha Raghavan, has previously sold two other companies, one with high returns and another at a lower value. This recent exit showcases Convergent Finance's ability to deliver substantial returns on its investments.
View Source
Did InvAscent beat the benchmark in exit from four-year-old pharma bet?
VCCircle
·
11m ago
Medial
InvAscent, a healthcare-focused private equity firm, has exited a four-year-old investment through a secondaries transaction. The firm, which is raising its fourth fund and has made three new deals within the past nine months, successfully beat the benchmark in this exit. InvAscent has crossed the halfway mark in June for its fourth fund, which focuses on healthcare investments.
View Source
Warburg continues exit spree with bumper returns despite disappointing run of portfolio co
VCCircle
·
11m ago
Medial
Warburg Pincus, a private equity firm, has recently sold off another portfolio company in India, marking a quick exit that yielded impressive returns. Despite facing a disappointing run with some of its portfolio companies, Warburg Pincus has been capitalizing on the strong market valuations in India, leading to a successful exit spree over the past two years.
View Source
InvAscent set to ramp up portfolio with new hospital deal
VCCircle
·
6m ago
Medial
India-based private equity firm InvAscent plans to invest in a multi-speciality hospital chain, marking its second deal of the month. Known for focusing on healthcare, InvAscent is currently raising its fourth investment fund. Last year, the firm executed three deals from this fund, signifying its active engagement in bolstering healthcare services through strategic investments in India. These moves illustrate InvAscent's ongoing commitment to expanding its portfolio within the healthcare sector.
View Source
Carlyle spins a quick multi-bagger in India
VCCircle
·
8m ago
Medial
Carlyle, a private equity firm, has made another exit move from a local portfolio company in India. The firm has previously logged partial exit moves this year and plans to sell a stake worth $1.2 billion in Hexaware through an IPO. Carlyle has been actively involved in the financial services sector in India and continues to explore investment opportunities in the country.
View Source
Trackers
Active Indian VC’s
OG Capital
Email
With a hands-on approach, OG Capital aims to invest in over 20 promising...
Accel Partners
Email
Early and growth-stage investments in disruptive technology companies with...
Blume
Email
Early-stage venture capital firm investing in technology startups in India. Focus on...
Access All Trackers
Startup Showcase Winners
June 2025
Buddy
Helping your parents when you are miles away
BiteStop
The Pit Stop Your Cravings Deserve
Bloomer
The next generation E-commerce platform
Enter Ongoing Startup Showcase
Top Users
Trending News on Medial
Download the medial app to read full posts, comements and news.
Go to Medial App
Not Now
Know everything that’s happening in the startup ecosystem, first.
Enable Notifications?
No, thanks
Count me in